Barriers to accessing care in patients with chronic hepatitis C: the impact of depression
Open Access
- 17 September 2010
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 32 (9) , 1163-1173
- https://doi.org/10.1111/j.1365-2036.2010.04460.x
Abstract
Aliment Pharmacol Ther 2010; 32: 1163–1173 Summary Background Patients with hepatitis C viral (HCV) may perceive barriers to accessing speciality care for HCV, and these barriers may be related to depressive symptoms. Aim To evaluate the relationship between barriers to care, demographics, and depressive symptoms. Methods A cross‐sectional analysis of 126 patients referred for HCV at two speciality HCV clinics. Barriers to care, depressive symptoms and sociodemographics were measured using standardized instruments. A retrospective chart review was conducted to collect clinical outcome data. Results Depressive symptoms were reported in 26%. Common barriers included lack of personal financial resources; lack of HCV knowledge in the community; lack of professionals competent in HCV care; stigmatization of HCV; and long distances to clinics offering care. After we controlled for sociodemographics, depression accounted for an additional 7–18% of variability in all barriers (all p values <0.01). Lower depression, marital and employment status were associated with subsequent receipt of HCV treatment in 38% (45/120) of patients; perceived barriers were not. Conclusions Depression is independently associated with perceived barriers to care. Higher depressive scores, but not perceived barriers, were associated with nontreatment. Healthcare providers who diagnose HCV need to be cognizant of numerous perceived barriers to accessing HCV care, and the impact that depression may have on these perceptions and receipt of treatment.Keywords
This publication has 48 references indexed in Scilit:
- Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 InfectionNew England Journal of Medicine, 2009
- Introduction: Chronic Medical Conditions and Depression—the View from Primary CareThe American Journal of Medicine, 2008
- Psychiatric symptoms during interferon treatment for hepatitis C:experiences from a tertiary care hepatology centreAlimentary Pharmacology & Therapeutics, 2008
- Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factorsGeneral Hospital Psychiatry, 2005
- The mediating role of health beliefs in the relationship between depressive symptoms and medication adherence in persons with diabetesResearch in Social and Administrative Pharmacy, 2005
- Barriers to the treatment of hepatitis CJournal of General Internal Medicine, 2005
- Challenges in the Treatment of Patients Coinfected with HIV and Hepatitis C Virus: Need for Team CareClinical Infectious Diseases, 2005
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Barriers to care among persons living with HIV/AIDS in urban and rural areasAIDS Care, 1998
- The CES-D ScaleApplied Psychological Measurement, 1977